Regencell Bioscience Holdings Ltd (RGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2021 | 12-2020 | 06-2020 | 06-2019 | 12-2017 | |
| Sales | 0 | 0 | 0 | 0 | 861,600 |
| Cost of Goods | N/A | N/A | N/A | N/A | 323,700 |
| Gross Profit | N/A | N/A | N/A | N/A | 537,900 |
| Operating Expenses | 0 | 0 | 0 | 0 | 447,900 |
| Operating Income | N/A | N/A | N/A | N/A | 90,700 |
| Interest Expense | 0 | 0 | 0 | 0 | 31,600 |
| Other Income | 0 | 0 | 0 | 0 | 10,100 |
| Pre-tax Income | 0 | 0 | 0 | 0 | 69,200 |
| Income Tax | N/A | N/A | N/A | N/A | 40,300 |
| Net Income Continuous | N/A | N/A | N/A | N/A | 28,900 |
| Net Income | $N/A | $N/A | $N/A | $N/A | $28,900 |
| EPS Basic Total Ops | N/A | N/A | N/A | N/A | 0.19 |
| EPS Basic Continuous Ops | N/A | N/A | N/A | N/A | 0.18 |
| EPS Diluted Total Ops | N/A | N/A | N/A | N/A | 0.19 |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | N/A | 0.18 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | N/A | -9,999.00 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $155,500 |